Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 2500.00 | 1067.09 | 3397.00 | 5130.00 | 0.6622 | 0.6673 |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 2500.00 | 1067.09 | 5446.00 | 5130.00 | 1.0616 | 1.0535 |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 2500.00 | 1067.09 | 5573.00 | 5130.00 | 1.0864 | 1.0745 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 2500.00 | 1067.09 | 5459.00 | 5130.00 | 1.0641 | 1.0556 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 2500.00 | 1067.09 | 5672.00 | 5130.00 | 1.1057 | 1.0907 |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 2500.00 | 1067.09 | 4735.00 | 5130.00 | 0.9230 | 0.9305 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 2500.00 | 1067.09 | 3600.00 | 5130.00 | 0.7018 | 0.7105 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 2500.00 | 1067.09 | 5685.00 | 5130.00 | 1.1082 | 1.0928 |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 2500.00 | 1067.09 | 1373.00 | 5130.00 | 0.2676 | 0.1177 |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 2500.00 | 1067.09 | 5640.00 | 5130.00 | 1.0994 | 1.0855 |
| MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 5458.00 | 5130.00 | 1.0639 | 1.0555 | |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 2500.00 | 1067.09 | 4015.00 | 5130.00 | 0.7827 | 0.7949 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 2500.00 | 1067.09 | 2651.00 | 5130.00 | 0.5168 | 0.4944 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 2500.00 | 1067.09 | 5616.00 | 5130.00 | 1.0947 | 1.0815 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 2500.00 | 1067.09 | 5406.00 | 5130.00 | 1.0538 | 1.0468 |
| MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 5199.00 | 5130.00 | 1.0135 | 1.0118 | |
| MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 5073.00 | 5130.00 | 0.9889 | 0.9902 | |
| MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 4998.00 | 5130.00 | 0.9743 | 0.9771 | |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 2500.00 | 1067.09 | 4884.00 | 5130.00 | 0.9521 | 0.9571 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 2500.00 | 1067.09 | 4716.00 | 5130.00 | 0.9193 | 0.9271 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 2500.00 | 1067.09 | 5241.00 | 5130.00 | 1.0216 | 1.0190 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 2500.00 | 1067.09 | 5236.00 | 5130.00 | 1.0207 | 1.0181 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 2500.00 | 1067.09 | 5356.00 | 5130.00 | 1.0441 | 1.0384 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 2500.00 | 1067.09 | 5285.00 | 5130.00 | 1.0302 | 1.0265 |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 2500.00 | 1067.09 | 5290.00 | 5130.00 | 1.0312 | 1.0273 |